1440 related articles for article (PubMed ID: 23452894)
1. Combination cell therapy using mesenchymal stem cells and regulatory T-cells provides a synergistic immunomodulatory effect associated with reciprocal regulation of TH1/TH2 and th17/treg cells in a murine acute graft-versus-host disease model.
Lim JY; Park MJ; Im KI; Kim N; Jeon EJ; Kim EJ; Cho ML; Cho SG
Cell Transplant; 2014 Apr; 23(6):703-14. PubMed ID: 23452894
[TBL] [Abstract][Full Text] [Related]
2. Inducible Costimulator Gene-Transduced Bone Marrow-Derived Mesenchymal Stem Cells Attenuate the Severity of Acute Graft-Versus-Host Disease in Mouse Models.
Yang D; Wang LP; Zhou H; Cheng H; Bao XC; Xu S; Zhang WP; Wang JM
Cell Transplant; 2015; 24(9):1717-31. PubMed ID: 25203502
[TBL] [Abstract][Full Text] [Related]
3. Placenta-derived mesenchymal stem cells have an immunomodulatory effect that can control acute graft-versus-host disease in mice.
Jang MJ; Kim HS; Lee HG; Kim GJ; Jeon HG; Shin HS; Chang SK; Hur GH; Chong SY; Oh D; Chung HM
Acta Haematol; 2013; 129(4):197-206. PubMed ID: 23257958
[TBL] [Abstract][Full Text] [Related]
4. Optimization of adipose tissue-derived mesenchymal stem cells by rapamycin in a murine model of acute graft-versus-host disease.
Kim KW; Moon SJ; Park MJ; Kim BM; Kim EK; Lee SH; Lee EJ; Chung BH; Yang CW; Cho ML
Stem Cell Res Ther; 2015 Oct; 6():202. PubMed ID: 26497134
[TBL] [Abstract][Full Text] [Related]
5. Adoptive Transfer of Treg Cells Combined with Mesenchymal Stem Cells Facilitates Repopulation of Endogenous Treg Cells in a Murine Acute GVHD Model.
Lee ES; Lim JY; Im KI; Kim N; Nam YS; Jeon YW; Cho SG
PLoS One; 2015; 10(9):e0138846. PubMed ID: 26393514
[TBL] [Abstract][Full Text] [Related]
6. Amelioration of acute graft-versus-host disease by adoptive transfer of ex vivo expanded human cord blood CD4+CD25+ forkhead box protein 3+ regulatory T cells is associated with the polarization of Treg/Th17 balance in a mouse model.
Yang J; Fan H; Hao J; Ren Y; Chen L; Li G; Xie R; Yang Y; Qian K; Liu M
Transfusion; 2012 Jun; 52(6):1333-47. PubMed ID: 22098312
[TBL] [Abstract][Full Text] [Related]
7. Blocking activator protein 1 activity in donor cells reduces severity of acute graft-versus-host disease through reciprocal regulation of IL-17-producing T cells/regulatory T cells.
Park MJ; Moon SJ; Lee SH; Kim EK; Yang EJ; Min JK; Park SH; Kim HY; Yang CW; Cho ML
Biol Blood Marrow Transplant; 2014 Aug; 20(8):1112-20. PubMed ID: 24813170
[TBL] [Abstract][Full Text] [Related]
8. Third-party regulatory T cells prevent murine acute graft-versus-host disease.
Lim JY; Im KI; Song Y; Kim N; Nam YS; Jeon YW; Cho SG
Korean J Intern Med; 2018 Sep; 33(5):980-989. PubMed ID: 29050459
[TBL] [Abstract][Full Text] [Related]
9. Mesenchymal stem cells administered after liver transplantation prevent acute graft-versus-host disease in rats.
Xia X; Chen W; Ma T; Xu G; Liu H; Liang C; Bai X; Zhang Y; He Y; Liang T
Liver Transpl; 2012 Jun; 18(6):696-706. PubMed ID: 22344929
[TBL] [Abstract][Full Text] [Related]
10. [Influence of mouse genetic engineering regulatory T cells infusion on post-allogeneic bone marrow transplantation acute graft-versus-host disease in mice].
Cao J; Li L; Chen C; Zeng LY; Li ZY; Pan XY; Xu KL
Zhonghua Xue Ye Xue Za Zhi; 2011 Feb; 32(2):83-8. PubMed ID: 21429372
[TBL] [Abstract][Full Text] [Related]
11. The immunosuppressive properties of non-cultured dermal-derived mesenchymal stromal cells and the control of graft-versus-host disease.
Gao L; Liu F; Tan L; Liu T; Chen Z; Shi C
Biomaterials; 2014 Apr; 35(11):3582-8. PubMed ID: 24468404
[TBL] [Abstract][Full Text] [Related]
12. CD4(+)CD25 (+) regulatory T cells are not required for mesenchymal stem cell function in fully MHC-mismatched mouse cardiac transplantation.
Jiang X; Liu C; Hao J; Guo D; Guo J; Yao J; Jiang K; Cui Z; Zhu L; Sun W; Lin L; Liang J
Cell Tissue Res; 2014 Nov; 358(2):503-14. PubMed ID: 25103227
[TBL] [Abstract][Full Text] [Related]
13. Bone marrow-derived conventional, but not cloned, mesenchymal stem cells suppress lymphocyte proliferation and prevent graft-versus-host disease in rats.
Kitazawa Y; Li XK; Xie L; Zhu P; Kimura H; Takahara S
Cell Transplant; 2012; 21(2-3):581-90. PubMed ID: 22793067
[TBL] [Abstract][Full Text] [Related]
14. Mesenchymal stem cells generate a CD4+CD25+Foxp3+ regulatory T cell population during the differentiation process of Th1 and Th17 cells.
Luz-Crawford P; Kurte M; Bravo-Alegría J; Contreras R; Nova-Lamperti E; Tejedor G; Noël D; Jorgensen C; Figueroa F; Djouad F; Carrión F
Stem Cell Res Ther; 2013 Jun; 4(3):65. PubMed ID: 23734780
[TBL] [Abstract][Full Text] [Related]
15. Immunomodulation effects of mesenchymal stromal cells on acute graft-versus-host disease after hematopoietic stem cell transplantation.
Zhao K; Lou R; Huang F; Peng Y; Jiang Z; Huang K; Wu X; Zhang Y; Fan Z; Zhou H; Liu C; Xiao Y; Sun J; Li Y; Xiang P; Liu Q
Biol Blood Marrow Transplant; 2015 Jan; 21(1):97-104. PubMed ID: 25300866
[TBL] [Abstract][Full Text] [Related]
16. IFN-γ production by allogeneic Foxp3+ regulatory T cells is essential for preventing experimental graft-versus-host disease.
Koenecke C; Lee CW; Thamm K; Föhse L; Schafferus M; Mittrücker HW; Floess S; Huehn J; Ganser A; Förster R; Prinz I
J Immunol; 2012 Sep; 189(6):2890-6. PubMed ID: 22869903
[TBL] [Abstract][Full Text] [Related]
17. Immunomodulatory effects of mesenchymal stem cells involved in favoring type 2 T cell subsets.
Lu X; Liu T; Gu L; Huang C; Zhu H; Meng W; Xi Y; Li S; Liu Y
Transpl Immunol; 2009 Dec; 22(1-2):55-61. PubMed ID: 19695330
[TBL] [Abstract][Full Text] [Related]
18. Donor Requirements for Regulatory T Cell Suppression of Murine Graft-versus-Host Disease.
Pierini A; Colonna L; Alvarez M; Schneidawind D; Nishikii H; Baker J; Pan Y; Florek M; Kim BS; Negrin RS
J Immunol; 2015 Jul; 195(1):347-55. PubMed ID: 25994967
[TBL] [Abstract][Full Text] [Related]
19. High expression of heme oxygenase-1 in target organs may attenuate acute graft-versus-host disease through regulation of immune balance of TH17/Treg.
Yu M; Wang J; Fang Q; Liu P; Chen S; Zhe N; Lin X; Zhang Y; Zhao J; Zhou Z
Transpl Immunol; 2016 Jul; 37():10-17. PubMed ID: 27168057
[TBL] [Abstract][Full Text] [Related]
20. The immunomodulatory effects of human mesenchymal stem cells on peripheral blood mononuclear cells in ALS patients.
Kwon MS; Noh MY; Oh KW; Cho KA; Kang BY; Kim KS; Kim YS; Kim SH
J Neurochem; 2014 Oct; 131(2):206-18. PubMed ID: 24995608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
